In our study, co‐overexpression of PGAP3 and ERBB2 was found in 88.13% ERBB2 high expressed GC patients and the expression of two genes were positively correlated, suggesting that PGAP3‐ERBB2 co‐expression may be common in GC. The gene discussed is ERBB2; the disease is gastric cancer.